Gene · 1890
Papers4,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights from the SNP analysis of TYMP gene linking MNGIE. | Bioinformation | 2024 | 38712004 | PubTator, text mining | PubMed |
| Heritability of Gene Expression Measured from Peripheral Blood in Older Adults. | Genes (Basel) | 2024 | 38674429 | PubTator, text mining | PubMed |
| Cochlear implantation in patients with Charcot-Marie-Tooth disease: two cases with a review of the literature. | Eur Arch Otorhinolaryngol | 2024 | 38582814 | PubTator, text mining | PubMed |
| Meningoencephalitis in a novel mutation in MNGIE (mitochondrial neurogastrointestinal encephalomyopathy) ending a familial diagnostic odyssey: A case series report. | J Cent Nerv Syst Dis | 2024 | 38550250 | PubTator, text mining | PubMed |
| Innovate therapeutic targets for autoimmune diseases: insights from proteome-wide mendelian randomization and Bayesian colocalization. | Autoimmunity | 2024 | 38515381 | PubTator, text mining | PubMed |
Comparison of efficacy and safety of 5-FU or capecitabine combined with cisplatin and docetaxel (mDCF and mDCX) as a first-line chemotherapy regimen in her 2-negative metastatic gastric cancer patients: A retrospective study. | Medicine (Baltimore) | 2024 | 38428877 | PubTator, text mining | PubMed |
| Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature. | Sci Rep | 2024 | 38310106 | PubTator, text mining | PubMed |
| Macrophage heterogeneity and its interactions with stromal cells in tumour microenvironment. | Cell Biosci | 2024 | 38303024 | PubTator, text mining | PubMed |
| A pilot study investigating plasma pharmacokinetics and tolerance of oral capecitabine in carcinoma-bearing dogs. | BMC Vet Res | 2024 | 38297307 | PubTator, text mining | PubMed |
| Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen 125, carbohydrate antigen 199 analysis. | World J Clin Cases | 2024 | 38292648 | PubTator, text mining | PubMed |
| Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma. | Genes (Basel) | 2024 | 38275602 | PubTator, text mining | PubMed |
| Exploring unconventional attributes of red blood cells and their potential applications in biomedicine. | Protein Cell | 2024 | 38270470 | PubTator, text mining | PubMed |
| The functional role of CST1 and CCL26 in asthma development. | Immun Inflamm Dis | 2024 | 38270326 | PubTator, text mining | PubMed |
| Genetic Polymorphisms and Tumoral Mutational Profiles over Survival in Advanced Colorectal Cancer Patients: An Exploratory Study. | Curr Oncol | 2024 | 38248103 | PubTator, text mining | PubMed |
| Involvement of Astrocytes in the Formation, Maintenance, and Function of the Blood-Brain Barrier. | Cells | 2024 | 38247841 | PubTator, text mining | PubMed |
| Atherosclerosis Vindicated: A Case of Chest Pain Due to Capecitabine-Induced Coronary Artery Spasm. | Am J Case Rep | 2024 | 38217283 | PubTator, text mining | PubMed |
| Drug-loaded erythrocytes: Modern approaches for advanced drug delivery for clinical use. | Heliyon | 2024 | 38192824 | PubTator, text mining | PubMed |
| Mendelian randomization identifies circulating proteins as biomarkers for age at menarche and age at natural menopause. | Commun Biol | 2024 | 38184718 | PubTator, text mining | PubMed |
| Red blood cells in biology and translational medicine: natural vehicle inspires new biomedical applications. | Theranostics | 2024 | 38164142 | PubTator, text mining | PubMed |
| 1,3,4-Oxadiazoles as Anticancer Agents: A Review. | Recent Pat Anticancer Drug Discov | 2024 | 37497702 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1890/papers?page=8